Selective Inhibition of Cytosolic PARylation via PARG99: A Targeted Approach for Mitigating FUS-associated Neurodegeneration
Preprint
Abstract
Neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) are characterized by complex etiologies, often involving disruptions in functions of RNA/DNA binding proteins (RDBPs) such as FUS and TDP-43. The cytosolic mislocalization and aggregation of these proteins are linked to accumulation of unresolved stress granules (SGs), which exacerbate the disease progression. Poly-ADP-ribose polymerase (PARP)-mediated PARylation plays a critical role in this pathological cascade, making it a potential target for intervention. However, conventional PARP inhibitors are limited by their detrimental effects on DNA repair pathways, which are already compromised in ALS. To address this limitation, we investigated a strategy focused on targeting the cytosolic compartment by expressing the cytosol-specific, natural PAR- glycohydrolase (PARG) isoform, PARG99. Using ALS patient derived FUS mutant induced pluripotent cells (iPSCs) and differentiated neurons, we observed elevated levels of FUS in insoluble fractions in mutant cells compared to mutation-corrected isogenic lines. The insoluble FUS as well as TDP-43 levels increased further in sodium arsenite-treated or oxidatively stressed cells, correlating with accumulation of unresolved SGs. Notably, both PARG99 and PARP inhibitors reduced SG formation and insoluble FUS levels, however, PARG99 treated cells exhibited significantly lower DNA damage markers and improved viability under oxidative and arsenite stress. This study highlights the potential of PARG99 as a cytosol-specific intervention to mitigate FUS-associated toxicity while preserving critical nuclear DNA repair mechanisms, offering a promising strategy for addressing the underlying pathology of ALS and potentially other SG-associated neurodegenerative diseases.Keywords
This publication has 53 references indexed in Scilit:
- ADP-ribosylation from molecular mechanisms to therapeutic implicationsCell, 2023
- DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent mannerActa Neuropathologica, 2021
- Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseasesLife Sciences, 2021
- G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress GranulesCell, 2020
- RNA Granules and Diseases: A Case Study of Stress Granules in ALS and FTLD2016
- The ALS/FTLD‐related RNA‐binding proteins TDP‐43 and FUS have common downstream RNA targets in cortical neuronsFEBS Open Bio, 2013
- FUS/TLS assembles into stress granules and is a prosurvival factor during hyperosmolar stressJournal of Cellular Physiology, 2013
- Molecular properties of TAR DNA binding protein-43 fragments are dependent upon its cleavage siteBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS geneActa Neuropathologica, 2011
- Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutationsAnnals of Neurology, 2007